Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine
Clinical trial NCT03028116 · COMPLETED
Trial details
- NCT number
- NCT03028116
- Sponsor
- Research Institute for Biological Safety Problems
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2016-06-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.